ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
28 10 2022
Historique:
entrez: 28 10 2022
pubmed: 29 10 2022
medline: 2 11 2022
Statut: ppublish

Résumé

B cells orchestrate autoimmune responses in patients with systemic lupus erythematosus (SLE), but broad-based B cell-directed therapies show only modest efficacy while blunting humoral immune responses to vaccines and inducing immunosuppression. Development of more effective therapies targeting pathogenic clones is a currently unmet need. Here, we demonstrate enhanced activation of the ATR/Chk1 pathway of the DNA damage response (DDR) in B cells of patients with active SLE disease. Treatment of B cells with type I IFN, a key driver of immunity in SLE, induced expression of ATR via binding of interferon regulatory factor 1 to its gene promoter. Pharmacologic targeting of ATR in B cells, via a specific inhibitor (VE-822), attenuated their immunogenic profile, including proinflammatory cytokine secretion, plasmablast formation, and antibody production. Together, these findings identify the ATR-mediated DDR axis as the orchestrator of the type I IFN-mediated B cell responses in SLE and as a potential novel therapeutic target.

Identifiants

pubmed: 36306362
doi: 10.1126/sciadv.abo5840
pmc: PMC9616496
doi:

Substances chimiques

ATR protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabo5840

Commentaires et corrections

Type : CommentIn

Références

J Biol Chem. 2008 Jun 20;283(25):17250-9
pubmed: 18448427
Cancer Lett. 2006 Nov 8;243(1):9-15
pubmed: 16530324
Nat Protoc. 2019 Jan;14(1):68-85
pubmed: 30464214
Bioinformatics. 2015 Jan 15;31(2):166-9
pubmed: 25260700
Cell Death Dis. 2020 Mar 3;11(3):164
pubmed: 32127533
JCI Insight. 2016 Jun 16;1(9):e87310
pubmed: 27699274
N Engl J Med. 2011 Dec 1;365(22):2110-21
pubmed: 22129255
Curr Biol. 2000 Jul 27-Aug 10;10(15):886-95
pubmed: 10959836
Cell Rep. 2015 May 5;11(5):785-797
pubmed: 25921537
Cell Metab. 2020 Oct 6;32(4):591-604.e7
pubmed: 32738205
Autoimmun Rev. 2015 Jan;14(1):75-9
pubmed: 25449682
Int J Mol Sci. 2021 May 29;22(11):
pubmed: 34072535
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Science. 2018 Aug 24;361(6404):806-810
pubmed: 30139873
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8563-8
pubmed: 8710910
Drugs. 2021 Oct;81(15):1795-1802
pubmed: 34554438
Proc Natl Acad Sci U S A. 2012 May 8;109(19):7344-9
pubmed: 22529391
J Immunol Res. 2016;2016:5281823
pubmed: 28116319
Oncotarget. 2017 Jan 24;8(4):6461-6474
pubmed: 28031537
Nat Med. 2016 Feb;22(2):146-53
pubmed: 26779811
J Nucleic Acids. 2010 Aug 03;2010:
pubmed: 20811597
Nat Commun. 2021 Mar 31;12(1):1980
pubmed: 33790300
J Clin Invest. 2017 Jun 30;127(7):2789-2804
pubmed: 28581446
Arthritis Rheum. 2012 Feb;64(2):568-78
pubmed: 21905016
Arthritis Res Ther. 2016 Aug 04;18(1):182
pubmed: 27492607
Nat Struct Mol Biol. 2011 Jun;18(6):721-7
pubmed: 21552262
Ann Rheum Dis. 2005 Oct;64(10):1507-9
pubmed: 16162903
Nucleic Acids Res. 2021 Jan 8;49(D1):D104-D111
pubmed: 33231677
Immunity. 2006 Sep;25(3):383-92
pubmed: 16979570
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Cell Death Differ. 2019 Dec;26(12):2551-2567
pubmed: 30894677
Cell Rep. 2014 Jan 16;6(1):1-8
pubmed: 24388753
Nucleic Acids Res. 2002 Jan 1;30(1):322-4
pubmed: 11752326
Front Immunol. 2015 May 13;6:228
pubmed: 26029213
Nat Immunol. 2004 Jan;5(1):55-63
pubmed: 14647274
Genes Dev. 2008 May 1;22(9):1147-52
pubmed: 18451105
N Engl J Med. 2016 Jun 30;374(26):2563-74
pubmed: 27355535
J Clin Invest. 2021 Jun 15;131(12):
pubmed: 34128474
Clin Exp Rheumatol. 2002 Sep-Oct;20(5):653-60
pubmed: 12412196
Ann Rheum Dis. 2021 Jan;80(1):14-25
pubmed: 33051219
Nat Commun. 2018 Apr 27;9(1):1698
pubmed: 29703886
Lupus Sci Med. 2016 Apr 29;3(1):e000148
pubmed: 27158526
J Leukoc Biol. 2021 Dec;110(6):1101-1112
pubmed: 33884660
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
J Cell Sci. 2004 Dec 1;117(Pt 25):6019-30
pubmed: 15536124
J Immunol Methods. 2010 Jun 30;358(1-2):56-65
pubmed: 20302874
Science. 2018 Jan 5;359(6371):108-114
pubmed: 29170278
Nat Commun. 2018 May 1;9(1):1758
pubmed: 29717110
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Lupus Sci Med. 2019 Aug 13;6(1):e000270
pubmed: 31497305
Cell Stem Cell. 2007 Jun 7;1(1):113-26
pubmed: 18371340
J Virol. 2015 Dec 30;90(6):2818-29
pubmed: 26719266
PLoS One. 2021 May 4;16(5):e0248886
pubmed: 33945543
J Immunol. 2017 Feb 15;198(4):1512-1520
pubmed: 28087671
Sci Rep. 2017 Oct 24;7(1):13921
pubmed: 29066741
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Nat Commun. 2013;4:2406
pubmed: 24009041
Proc Natl Acad Sci U S A. 2017 Jun 13;114(24):E4782-E4791
pubmed: 28533414
Nat Commun. 2018 Dec 17;9(1):5351
pubmed: 30559436
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Commun. 2017 Nov 22;8(1):1697
pubmed: 29167438
Front Immunol. 2018 Nov 20;9:2698
pubmed: 30524439
Lupus. 2002;11(4):234-9
pubmed: 12043887
Leukemia. 2005 Aug;19(8):1471-8
pubmed: 15959530
Nat Immunol. 2019 Aug;20(8):1071-1082
pubmed: 31263277
Arthritis Rheumatol. 2018 Apr;70(4):496-507
pubmed: 29207444
Mol Cell. 2009 May 15;34(3):285-97
pubmed: 19450527
Nat Rev Immunol. 2019 Apr;19(4):231-242
pubmed: 30778174
EMBO J. 2016 Jan 4;35(1):6-23
pubmed: 26628622
Nat Cell Biol. 2009 Aug;11(8):973-9
pubmed: 19597488
Cell Rep. 2018 Jul 10;24(2):406-418
pubmed: 29996101
Mol Cell. 2015 Sep 17;59(6):1011-24
pubmed: 26365377
Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188521
pubmed: 33556453
Ann Rheum Dis. 2019 Sep;78(9):1151-1159
pubmed: 31383717
Lupus. 2015 Jul;24(8):804-15
pubmed: 25542905
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
Oncotarget. 2015 Mar 30;6(9):6553-69
pubmed: 25544753
J Pharmacol Exp Ther. 2016 Oct;359(1):37-44
pubmed: 27440419
Elife. 2017 Mar 31;6:
pubmed: 28362262
Mol Cancer Ther. 2019 Jul;18(7):1255-1264
pubmed: 31064869
Sci Transl Med. 2019 Nov 20;11(519):
pubmed: 31748230
J Virol. 2020 Jun 16;94(13):
pubmed: 32321819
Arthritis Rheum. 2010 Aug;62(8):2412-23
pubmed: 20506108
Leukemia. 2022 Jan;36(1):197-209
pubmed: 34304248
Cell Res. 2015 Jan;25(1):9-23
pubmed: 25403473
Nat Immunol. 2007 Jul;8(7):705-14
pubmed: 17558410
Front Immunol. 2021 Nov 03;12:763412
pubmed: 34804051
Curr Biol. 2000 Apr 20;10(8):479-82
pubmed: 10801416
Br J Cancer. 2021 Aug;125(4):510-519
pubmed: 34040175

Auteurs

Theodora Manolakou (T)

Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

Dionysis Nikolopoulos (D)

Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.

Dimitrios Gkikas (D)

Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, 115 27, Athens, Greece.

Anastasia Filia (A)

Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.

Martina Samiotaki (M)

Institute for Bioinnovation, Biomedical Sciences Research Center Alexander Fleming, Vari, Attica, Greece.
Centre of New Biotechnologies and Precision Medicine (CNBPM) School of Medicine, National and Kapodistrian University of Athens, Athens 115 27, Greece.

George Stamatakis (G)

Institute for Bioinnovation, Biomedical Sciences Research Center Alexander Fleming, Vari, Attica, Greece.
Centre of New Biotechnologies and Precision Medicine (CNBPM) School of Medicine, National and Kapodistrian University of Athens, Athens 115 27, Greece.

Antonis Fanouriakis (A)

Department of Rheumatology, Asklepieion General Hospital, Athens, Greece.

Panagiotis Politis (P)

Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, 115 27, Athens, Greece.
School of Medicine, European University Cyprus, 1516, Nicosia, Cyprus.

Aggelos Banos (A)

Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.

Themis Alissafi (T)

Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, 115 27, Athens, Greece.
Laboratory of Biology, National and Kapodistrian University of Athens Medical School, 124 62 Athens, Greece.

Panayotis Verginis (P)

Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, 700 13 Heraklion, Greece.
Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, University of Crete Medical School, 700 13 Heraklion, Greece.

Dimitrios T Boumpas (DT)

Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.
Joint Rheumatology Program, 4th Department of Internal Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, 124 62 Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH